Speaker Profile

Ph.D., Sr. Director, Product Development, Invivoscribe

Dr. Ying Huang has over 25 years of research and industry experience with a broad knowledge in technology and assay development. Ying is passionate about developing novel methods using cutting edge technologies to improve lives with precision diagnostics. Her current work involves applying Invivoscribe assays to MRD detection in hematologic disease samples. Prior to Invivoscribe, she worked at Illumina, Acea Biosciences, Nanogen and MD Anderson Cancer Center. In those roles, she developed a variety of methods ranging from isolating CTC using microfluidic devices to detecting biowarfare agents using electronic microarray. She is co-author of more than 60 publications and abstracts and is co-inventor of 9 patents. Ying received her Ph.D in Electrical Engineering from Bangor University, UK.

Clinical Dx Showcase:

Invivoscribe is a global leader in hemato-oncology diagnostics. Our flow & molecular assays, reagents, controls, bioinformatics & services focus on actionable biomarkers supporting therapeutic decisions, MRD testing, stratification & CDx development.

AML MRD Testing Using Flow and NGS
MRD has become an important role as potential diagnostic, prognostics, efficacy-response and monitoring biomarker in AML. Invivoscribe offers complementary AML MRD testing using a comprehensive 12-color flow cytometry assay and a 53-gene NGS panel with limited primary samples.

 Session Abstract – PMWC 2022 Silicon Valley

The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative